Qixue Wang

6.0k total citations
85 papers, 3.7k citations indexed

About

Qixue Wang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Qixue Wang has authored 85 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 38 papers in Cancer Research and 18 papers in Genetics. Recurrent topics in Qixue Wang's work include Cancer-related molecular mechanisms research (22 papers), Glioma Diagnosis and Treatment (18 papers) and RNA Research and Splicing (13 papers). Qixue Wang is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), Glioma Diagnosis and Treatment (18 papers) and RNA Research and Splicing (13 papers). Qixue Wang collaborates with scholars based in China, United States and Portugal. Qixue Wang's co-authors include Chunsheng Kang, Yunfei Wang, Junhu Zhou, Kaikai Yi, Yanli Tan, Lei Han, Chao Yang, Jingxuan Yang, Chuan Fang and Xiaoteng Cui and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Qixue Wang

82 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qixue Wang China 35 2.7k 1.8k 372 350 340 85 3.7k
Chuanlu Jiang China 33 2.1k 0.8× 1.6k 0.9× 574 1.5× 336 1.0× 231 0.7× 72 3.0k
Xiao Gao China 23 1.6k 0.6× 1.1k 0.6× 221 0.6× 211 0.6× 551 1.6× 49 2.3k
Lei Han China 34 2.7k 1.0× 2.0k 1.1× 351 0.9× 399 1.1× 219 0.6× 121 3.7k
Miguel A. Esteban China 40 4.2k 1.5× 1.2k 0.7× 280 0.8× 298 0.9× 149 0.4× 87 5.1k
Ramani Ramchandran United States 35 3.0k 1.1× 1.5k 0.8× 200 0.5× 510 1.5× 324 1.0× 96 4.3k
Darren N. Saunders Australia 32 2.1k 0.8× 825 0.5× 237 0.6× 715 2.0× 236 0.7× 69 3.3k
Bo Hu United States 39 3.4k 1.3× 1.9k 1.1× 727 2.0× 1.1k 3.3× 577 1.7× 107 5.2k
Andrew C. Dudley United States 33 1.8k 0.7× 914 0.5× 165 0.4× 662 1.9× 448 1.3× 60 3.2k
Peiyu Pu China 42 4.6k 1.7× 3.5k 1.9× 429 1.2× 435 1.2× 244 0.7× 121 5.8k
Antonis K. Hatzopoulos United States 40 3.5k 1.3× 575 0.3× 499 1.3× 463 1.3× 461 1.4× 84 5.1k

Countries citing papers authored by Qixue Wang

Since Specialization
Citations

This map shows the geographic impact of Qixue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qixue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qixue Wang more than expected).

Fields of papers citing papers by Qixue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qixue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qixue Wang. The network helps show where Qixue Wang may publish in the future.

Co-authorship network of co-authors of Qixue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qixue Wang. A scholar is included among the top collaborators of Qixue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qixue Wang. Qixue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Chao, et al.. (2025). EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy. Free Radical Biology and Medicine. 232. 367–381. 2 indexed citations
2.
Hong, Biao, Shixue Yang, Xing Cui, et al.. (2025). Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma. Acta Pharmaceutica Sinica B. 15(7). 3632–3645.
3.
Yang, Eryan, Biao Hong, Yunfei Wang, et al.. (2024). EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma. Cancer Letters. 588. 216812–216812. 10 indexed citations
4.
Cui, Xiaoteng, et al.. (2024). Levetiracetam: A Potent Sword against Microglia Polarization in Gliomas. Clinical Cancer Research. 30(6). 1073–1075. 2 indexed citations
5.
Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations
6.
Lei, Xin, Yanli Tan, Xiaoteng Cui, et al.. (2023). EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT. Neuro-Oncology. 25(11). 1976–1988. 12 indexed citations
7.
Cui, Xiaoteng, Yunfei Wang, Junhu Zhou, Qixue Wang, & Chunsheng Kang. (2023). Expert opinion on translational research for advanced glioblastoma treatment. Cancer Biology and Medicine. 20(5). 1–9. 13 indexed citations
8.
Zhou, Nian, et al.. (2023). Effects of electroacupuncture on urinary metabolome and microbiota in presenilin1/2 conditional double knockout mice. Frontiers in Microbiology. 13. 1047121–1047121. 8 indexed citations
10.
Chen, Juan, Xing Wang, Naiping Song, Qixue Wang, & Xudong Wu. (2022). Water utilization of typical plant communities in desert steppe, China. Journal of Arid Land. 14(9). 1038–1054. 13 indexed citations
11.
Qin, Di, et al.. (2021). Putting Proteomics Into Immunotherapy for Glioblastoma. Frontiers in Immunology. 12. 593255–593255. 14 indexed citations
12.
Zhou, Nian, Yongkang Wu, Qixue Wang, et al.. (2021). Urinary metabolomic changes and microbiotic alterations in presenilin1/2 conditional double knockout mice. Journal of Translational Medicine. 19(1). 351–351. 14 indexed citations
13.
Li, Yansheng, Xing Liu, Xiaoteng Cui, et al.. (2021). LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis. Theranostics. 11(9). 4516–4530. 45 indexed citations
14.
Chen, Luyue, Junhu Zhou, Qixue Wang, et al.. (2020). TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biology and Medicine. 17(3). 664–675. 5 indexed citations
15.
Han, Lei, Chaoyong Liu, Hongzhao Qi, et al.. (2019). Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy. Advanced Materials. 31(19). e1805697–e1805697. 110 indexed citations
16.
Ren, Yu, Yunfei Wang, Jing Zhang, et al.. (2019). Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2. Clinical Epigenetics. 11(1). 29–29. 73 indexed citations
17.
Li, Yansheng, Yu Ren, Yunfei Wang, et al.. (2019). A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 9(16). 4608–4623. 84 indexed citations
18.
Chen, Qun, Jinquan Cai, Qixue Wang, et al.. (2017). Long Noncoding RNA NEAT1 , Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/ β -Catenin Pathway by Scaffolding EZH2. Clinical Cancer Research. 24(3). 684–695. 265 indexed citations
19.
Yang, Chao, Yansheng Li, Qixue Wang, et al.. (2017). EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells. Cancer Letters. 403. 119–127. 17 indexed citations
20.
Ma, Xingzhe, Ying Liu, Qixue Wang, et al.. (2015). Tamoxifen induces the development of hernia in mice by activating MMP-2 and MMP-13 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 1038–1048. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026